Australian human tissue revision to clarify industry's confusion
This article was originally published in Clinica
Executive Summary
Current Australian therapeutic goods legislation does not adequately regulate the manufacture, storage and use of human cell, tissue and cellular and tissue-based products (HCT/Ps) and is therefore in need of urgent revision.